Nuveen Asset Management, LLC Adverum Biotechnologies, Inc. Transaction History

Nuveen Asset Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.81 - $1.34 $277,925 - $459,778	-343,118 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.23 - $1.95 $815 - $1,292	663 Added 0.19%	343,118 $3.49 Million
Q4 2021 Feb 14, 2022	SELL	$1.74 - $2.4 $49,729 - $68,592	-28,580 Reduced 7.7%	342,455 $3.48 Million
Q3 2021 Nov 12, 2021	SELL	$2.08 - $3.6 $216,390 - $374,522	-104,034 Reduced 21.9%	371,035 $3.77 Million
Q2 2021 Aug 16, 2021	BUY	$3.36 - $10.56 $156,488 - $491,821	46,574 Added 10.87%	475,069 $4.83 Million
Q1 2021 May 17, 2021	BUY	$9.26 - $14.36 $289,532 - $448,994	31,267 Added 7.87%	428,495 $4.23 Million
Q4 2020 Feb 16, 2021	BUY	$9.84 - $14.26 $11,975 - $17,354	1,217 Added 0.31%	397,228 $4.31 Million
Q3 2020 Nov 16, 2020	BUY	$10.3 - $21.64 $415,399 - $872,741	40,330 Added 11.34%	396,011 $4.08 Million
Q2 2020 Aug 14, 2020	BUY	$8.53 - $25.64 $924,660 - $2.78 Million	108,401 Added 43.84%	355,681 $7.43 Million
Q1 2020 May 14, 2020	BUY	$7.98 - $16.32 $255,104 - $521,717	31,968 Added 14.85%	247,280 $2.42 Million
Q4 2019 Feb 14, 2020	BUY	$5.12 - $12.22 $21,294 - $50,822	4,159 Added 1.97%	215,312 $2.48 Million
Q3 2019 Nov 14, 2019	SELL	$5.24 - $15.89 $21,007 - $63,703	-4,009 Reduced 1.86%	211,153 $1.15 Million
Q2 2019 Aug 15, 2019	BUY	$5.1 - $11.89 $1.1 Million - $2.56 Million	215,162 New	215,162 $2.56 Million

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.